Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects*; D004789:Enzyme Activation / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000201:enzymology / Q000378:metabolism; D007700:Kinetics; D008566:Membranes / Q000378:metabolism; D051381:Rats; D013329:Structure-Activity Relationship; D013552:Swine; D014667:Vasopressins / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D014667:Vasopressins; D001127:Arginine Vasopressin; D000262:Adenylyl Cyclases